Sol Gel Technologies Ltd
NASDAQ:SLGL
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.366
1.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Sol Gel Technologies Ltd
EV/IC
Enterprise Value to IC
Enterprise Value to Invested Capital (EV/IC) ratio is a valuation multiple that measures the dollars in Enterprise Value for each dollar of capital invested by shareholders and lenders.
| Market Cap | EV/IC | ||||
|---|---|---|---|---|---|
| IL |
|
Sol Gel Technologies Ltd
NASDAQ:SLGL
|
14.9m USD | -1.5 | |
| JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | 4 032 690.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
710.5B USD | 10.6 | |
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 326.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
3.3T DKK | 11 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
373.5B USD | 2.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
251.1B USD | 2.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
202.7B CHF | 2.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
183.3B CHF | 2.7 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
162.4B GBP | 34.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
146B USD | 35.1 |
EV/IC Forward Multiples
Forward EV/IC multiple is a version of the EV/IC ratio that uses forecasted invested capital for the EV/IC calculation. 1-Year, 2-Years, and 3-Years forwards use invested capital forecasts for 1, 2, and 3 years ahead, respectively.
You don't have any saved screeners yet
